The biochemical characterization of three forms of Ku86 protein in multiple myeloma cell lines.

被引：0
|
作者：
Gullo, CA
Ge, F
Cow, G
Teoh, G
机构：
[1] Singapore Gen Hosp, Singapore 0316, Singapore
[2] Singapore Hlth Serv, Multiple Myeloma Res Lab, Singapore, Singapore
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3416
引用
收藏
页码：954A / 954A
页数：1
相关论文
共 50 条
  • [21] Ku86v translocates into cell membrane and associates with Ku70 in human multiple myeloma (MM) cells.
    Tai, YT
    Podar, K
    Hideshima, T
    Wang, FF
    Davies, FE
    Young, G
    Chauhan, D
    Lin, B
    Treon, SP
    Mitsiades, CS
    Lentzsch, S
    Gupta, D
    Hayashi, T
    Mitsiades, N
    Raje, N
    Koike, M
    Taccioli, GE
    Anderson, KC
    BLOOD, 2000, 96 (11) : 158A - 158A
  • [22] Multiple chromosome translocations within the IgH gene involving several oncogene loci in multiple myeloma cell lines.
    Taniwaki, M
    Nishida, K
    Nakazawa, N
    Tamura, T
    Lida, S
    Seto, M
    Ueda, R
    Kashima, K
    BLOOD, 1998, 92 (10) : 256A - 256A
  • [23] Effects of a thalidomide analog on binding activity of transcription factors and cell cycle progression of multiple myeloma cell lines.
    Payvandi, F
    Wu, L
    Gupta, D
    Hideshima, T
    Haley, M
    Muller, G
    Chen, R
    Anderson, KC
    Stirling, S
    BLOOD, 2000, 96 (11) : 579A - +
  • [24] Role of the phosphatidylinositol 3-kinase/Akt pathway in the proliferation and apoptosis of multiple myeloma cell lines.
    Pene, F
    Claessens, YE
    Mayeux, P
    Lacombe, C
    Roux, C
    Dreyfus, F
    Bouscary, D
    BLOOD, 2001, 98 (11) : 640A - 641A
  • [25] Characterization of the Effects of Pim Kinase Inhibition on Multiple Oncogene-Driven Cell Lines.
    Gross, Stefan David
    Robinson, John E.
    Allen, Shelley
    Cox, April
    DeWolf, Wait E.
    Galbraith, Sarah
    Lee, Patrice
    Lemieux, Christine
    Lyssikatos, Joseph P.
    Marmsater, Fredrik
    Martinson, Matthew
    Munson, Mark C.
    Wallace, Ross D.
    Woessner, Rich
    Zuzack, John
    Winkler, James
    Koch, Kevin
    BLOOD, 2008, 112 (11) : 920 - 920
  • [26] Characterization of resistance to APO010, a recombinant hexameric FAS ligand, in human myeloma cell lines.
    Jandu, Haatisha
    Nielsen, Annette
    Brunner, Nils
    Hansen, Anker
    Knudsen, Steen
    Jensen, Peter Buhl
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Expression and functional activity of CD52 antigen on primary plasma cells and multiple myeloma cell lines.
    Carlo-Stella, C
    Di Nicola, M
    Longoni, P
    Milanesi, M
    Milani, R
    Carrabba, M
    Gianni, AM
    Corradini, P
    BLOOD, 2003, 102 (11) : 890A - 890A
  • [28] A model for studying immunoglobulin heavy chain switch region translocations and clonal evolution in multiple myeloma cell lines.
    Shen, J
    Poh, CK
    Tham, SC
    Pin, LP
    Hwang, W
    Ng, HJ
    Chuah, C
    Loh, Y
    Teoh, G
    BLOOD, 2002, 100 (11) : 377B - 377B
  • [29] The Comprehensive Genomic Characterization of All Commercially Available Multiple Myeloma Cell Lines
    Yellapantula, Venkata D.
    Edwards, David K.
    Allen, Kristi
    Albanese, Jessica
    Babos, Kimberly
    Kurdoglu, Ahmet
    Liang, Winnie
    Tembe, Waibhav
    Keats, Jonathan J.
    BLOOD, 2012, 120 (21)
  • [30] Characterization of the protein S gene promoter and identification of transcriptional start sites in various cell lines.
    de Wolf, CJF
    Bertina, RM
    Vos, HL
    BLOOD, 2001, 98 (11) : 258A - 258A
12345